Real Life Study in Myopic Neovascularization (VIC)

Poitiers University Hospital

Status: Unknown

Conditions: Myopic Choroidal Neovascularisation

Treatments: Other: AFLIBERCEPT

Study type: Observational

Funder types: Other

Identifiers

NCT03797547

VIC

Details and patient eligibility

About

This is a multi centre, single arm, prospective observational phase 4 study in naive or pretreated patients with myopic neovascularization. The patients will be treated with intravitreal injections of Aflibercept following a real life protocol.

This sudy aims to evaluate the visual acuity during a 36 months period of time.

Enrollment: 24 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Man or woman aged 18 years and more under reliable method of contraception for woman with childbearing potenteial (hormonal or any intrauterine devices).

• High myopy defined by refractive error ≤ -6 D or History of high myopia among pseudophakic patient or patient treated with refractive surgery

• Patient with active CNVm

• • Patients naïve or Patients pretreated with previous history of laser photocoagulation or PDT or by other anti-VEGF treatments who did not receive injection since the last 3 month

  • with OCT or angiography examination

Exclusion criteria

• Treatment with an anti VEGF administrated by intravitreal injection within 1 months prior to baseline in the study eye.
• Treatment with PDT or laser administrated within 6 months prior to baseline in the study eye.
• History of vitrectomy in the study eye
• History of any other retinal disease
• VA less than 20/250